$2.31
1.50% today
NYSE, Dec 11, 09:20 pm CET
ISIN
US35168W1036
Symbol
GUTS

Fractyl Health Stock price

$2.34
+1.22 108.93% 1M
+0.18 8.33% 6M
+0.28 13.59% YTD
-0.18 7.14% 1Y
-12.66 84.40% 3Y
-12.66 84.40% 5Y
-12.66 84.40% 10Y
-12.66 84.40% 20Y
NYSE, Closing price Wed, Dec 10 2025
+0.05 2.18%
ISIN
US35168W1036
Symbol
GUTS

Key metrics

Basic
Market capitalization
$320.7m
Enterprise Value
$273.8m
Net debt
positive
Cash
$77.7m
Shares outstanding
132.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
26.3%
Return on Equity
-247.8%
ROCE
-103.3%
ROIC
-
Debt/Equity
-9.7
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-97.7m | $-104.3m
EBIT
$-98.7m | $-102.2m
Net Income
$-122.2m | $-219.6m
Free Cash Flow
$-86.8m
Growth (TTM | estimate)
Revenue
-100.0% | -100.0%
EBITDA
-20.9% | -12.3%
EBIT
-21.5% | -9.2%
Net Income
-77.2% | -211.7%
Free Cash Flow
-42.9%
Margin (TTM | estimate)
Gross
100.0%
EBITDA
-3,255,633.3% | -
EBIT
-3,291,400.0%
Net
-4,073,233.3% | -
Free Cash Flow
-2,893,766.7%
More
EPS
$-1.9
FCF per Share
$-0.7
Short interest
6.1%
Employees
103
Rev per Employee
$0.0
Show more

Is Fractyl Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,085 stocks worldwide.

Fractyl Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Fractyl Health forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Fractyl Health forecast:

Buy
91%
Hold
9%

Financial data from Fractyl Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 20 20
3% 3%
-
- Research and Development Expense 78 78
30% 30%
-
-98 -98
21% 21%
-
- Depreciation and Amortization 1.07 1.07
118% 118%
-
EBIT (Operating Income) EBIT -99 -99
21% 21%
-
Net Profit -122 -122
77% 77%
-

In millions USD.

Don't miss a Thing! We will send you all news about Fractyl Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fractyl Health Stock News

Neutral
GlobeNewsWire
9 days ago
Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment
Neutral
GlobeNewsWire
10 days ago
BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in a fireside chat...
Neutral
Seeking Alpha
29 days ago
Fractyl Health, Inc. ( GUTS ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Brian Luque - Head of Investor Relations & Corporate Development Harith Rajagopalan - Co-Founder, CEO & Director Lisa Davidson - CFO & Treasurer Conference Call Participants Chi Meng Fong - BofA Securities, Research Division Michael DiFiore - Evercore ISI Institutional Equities, Research Divis...
More Fractyl Health News

Company Profile

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Head office United States
CEO Harith Rajagopalan
Employees 103
Founded 2010
Website www.fractyl.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today